Stressed Liver and Muscle Call on Adipocytes with FGF21
Fibroblast growth factor 21 (FGF21) is an emerging regulator of local and systemic metabolic homeostasis. Treatment with pharmacological levels of FGF21 alleviates obesity and associated metabolic diseases including diabetes. However, beyond antiobesogenic effects, the normal roles and underlying m...
Main Authors: | Yongde eLuo, Wallace L. McKeehan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-12-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2013.00194/full |
Similar Items
-
Editorial: Novel strategies targeting obesity and metabolic diseases, volume II
by: Xinran Ma, et al.
Published: (2024-01-01) -
Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress
by: Yang Chaofeng, et al.
Published: (2012-10-01) -
MicroRNA Profile of Mouse Adipocyte-Derived Extracellular Vesicles
by: Tamás Röszer
Published: (2024-08-01) -
FGF21 and its underlying adipose tissue-liver axis inform cardiometabolic burden and improvement in obesity after metabolic surgeryResearch in context
by: Marie Patt, et al.
Published: (2024-12-01) -
Deletion of miPEP in adipocytes protects against obesity and insulin resistance by boosting muscle metabolism
by: Alexis Diaz-Vegas, et al.
Published: (2024-08-01)